These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27884585)

  • 21. Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer.
    Kelsen DP; Martin D; O'Neil J; Schwartz G; Saltz L; Sung MT; von Borstel R; Bertino J
    J Clin Oncol; 1997 Apr; 15(4):1511-7. PubMed ID: 9193347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
    Bocci G; Barbara C; Vannozzi F; Di Paolo A; Melosi A; Barsanti G; Allegrini G; Falcone A; Del Tacca M; Danesi R
    Clin Pharmacol Ther; 2006 Oct; 80(4):384-95. PubMed ID: 17015056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New formulation of 5-fluorouracil in microspheres reduces toxicity in mice.
    Hagiwara A; Sakakura C; Tsujimoto H; Ohgaki M; Imanishi T; Yamazaki J; Sawai K; Takahashi T; Yamamoto A; Muranishi S; Tabata Y; Ikada Y
    Anticancer Drugs; 1996 Sep; 7(7):780-4. PubMed ID: 8949990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [5-FU: At last!].
    Robert J
    Bull Cancer; 2019 Mar; 106(3):173-174. PubMed ID: 30837157
    [No Abstract]   [Full Text] [Related]  

  • 27. 5-Fluorouracil Neurotoxicity in a Patient With Normal Dihydropyrimidine Dehydrogenase Activity.
    Natarajan U; Onyechi A; Ohemeng-Dapaah J
    Cureus; 2023 Dec; 15(12):e49898. PubMed ID: 38174188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
    Shaib W; Lee V; Saif MW
    In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent combination therapy for human breast tumors with high doses of 5-fluorouracil: remission and lack of host toxicity.
    Al Safarjalani ON; Rais R; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1449-55. PubMed ID: 22373605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU.
    Gamelin EC; Danquechin-Dorval EM; Dumesnil YF; Maillart PJ; Goudier MJ; Burtin PC; Delva RG; Lortholary AH; Gesta PH; Larra FG
    Cancer; 1996 Feb; 77(3):441-51. PubMed ID: 8630950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-fluorouracil toxicity with severe bone marrow suppression in a dog.
    Fry MM; Forman MA
    Vet Hum Toxicol; 2004 Aug; 46(4):178-80. PubMed ID: 15303385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Metabolic Inhibitors on the Hepatic Disposition of 5-Fluorouracil after Application to the Rat Liver Surface.
    Shimokawa K; Wakasugi K; Tomonaga R; Utsunomiya K; Miyamoto H; Fumoto S; Nishida K
    Biol Pharm Bull; 2016; 39(3):361-7. PubMed ID: 26934928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
    Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men.
    Richel O; Wieland U; de Vries HJ; Brockmeyer NH; van Noesel C; Potthoff A; Prins JM; Kreuter A
    Br J Dermatol; 2010 Dec; 163(6):1301-7. PubMed ID: 20716208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer.
    Gamelin E; Delva R; Jacob J; Merrouche Y; Raoul JL; Pezet D; Dorval E; Piot G; Morel A; Boisdron-Celle M
    J Clin Oncol; 2008 May; 26(13):2099-105. PubMed ID: 18445839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.
    Ho YF; Lu WC; Chen RR; Cheng AL; Yeh KH
    Anticancer Drugs; 2011 Mar; 22(3):290-8. PubMed ID: 21150775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-fluorouracil Toxicity Mechanism Determination in Human Keratinocytes: in vitro Study on HaCaT Cell Line.
    Hartinger J; Veselý P; Šíma M; Netíková I; Matoušková E; Petruželka L
    Prague Med Rep; 2017; 118(4):128-138. PubMed ID: 29324220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
    Cao D; Russell RL; Zhang D; Leffert JJ; Pizzorno G
    Cancer Res; 2002 Apr; 62(8):2313-7. PubMed ID: 11956089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil.
    Baker SD; Diasio RB; O'Reilly S; Lucas VS; Khor SP; Sartorius SE; Donehower RC; Grochow LB; Spector T; Hohneker JA; Rowinsky EK
    J Clin Oncol; 2000 Feb; 18(4):915-26. PubMed ID: 10673535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.